Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 9, 2010 - Issue 4
Submit an article Journal homepage
435
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials

Jerry A Hall Abbott Laboratories, Indianapolis, USA
, MD,
Fujun Wang Eli Lilly and Company, Lilly Corporate Center DC4103, Indianapolis, IN 46285, USA +1 317 433 9399; +1 317 651 6269; [email protected]
, PhD,
Tina M Myers Oakes Eli Lilly and Company, Lilly Corporate Center DC4103, Indianapolis, IN 46285, USA +1 317 433 9399; +1 317 651 6269; [email protected]
, PhD,
Barbara G Utterback Eli Lilly and Company, Lilly Corporate Center DC4103, Indianapolis, IN 46285, USA +1 317 433 9399; +1 317 651 6269; [email protected]
, MS MBA,
Antonio Crucitti Novartis Vaccines and Diagnostics Via Fiorentina, 1, 53100 Siena, Italy
, MD &
Nayan Acharya Eli Lilly and Company, Lilly Corporate Center DC4103, Indianapolis, IN 46285, USA +1 317 433 9399; +1 317 651 6269; [email protected]
, MD
Pages 525-537 | Published online: 14 May 2010

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Dustin Anderson & Douglas W. Zochodne. (2016) Current Ideas on the Treatment Of Diabetic Neuropathies. Expert Review of Endocrinology & Metabolism 11:2, pages 187-195.
Read now
Dawn A Marcus. (2011) Duloxetine use in painful conditions. Expert Opinion on Pharmacotherapy 12:8, pages 1333-1340.
Read now

Articles from other publishers (15)

David J. Robinson, Kimberley Hanson, Akshay B. Jain, Jessica C. Kichler, Gaurav Mehta, Osnat C. Melamed, Michael Vallis, Harpreet S. Bajaj, Tracy Barnes, Jeremy Gilbert, Kristin Honshorst, Robyn Houlden, James Kim, Joanne Lewis, Barbara MacDonald, Dylan MacKay, Kerry Mansell, Doreen Rabi, Diana Sherifali & Peter Senior. (2023) Diabetes and Mental Health. Canadian Journal of Diabetes 47:4, pages 308-344.
Crossref
Francesca L. Beaudoin, Rachel Gaither, Weston C. DeLomba & Samuel A. McLean. (2023) Tolerability and efficacy of duloxetine for the prevention of persistent musculoskeletal pain after trauma and injury: a pilot three-group randomized controlled trial. Pain 164:4, pages 855-863.
Crossref
Isabelle Austin-Zimmerman, Marta Wronska, Baihan Wang, Haritz Irizar, Johan H. Thygesen, Anjali Bhat, Spiros Denaxas, Ghazaleh Fatemifar, Chris Finan, Jasmine Harju-Seppänen, Olga Giannakopoulou, Karoline Kuchenbaecker, Eirini Zartaloudi, Andrew McQuillin & Elvira Bramon. (2021) The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics. Genes 12:11, pages 1758.
Crossref
Asger Sand Paludan-Müller, Tarang Sharma, Kristine Rasmussen & Peter C. Gøtzsche. (2021) Extensive selective reporting of quality of life in clinical study reports and publications of placebo-controlled trials of antidepressants. International Journal of Risk & Safety in Medicine 32:2, pages 87-99.
Crossref
Daniel H Strauss, Divya R Santhanam, Samuel A McLean & Francesca L Beaudoin. (2019) Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain). BMJ Open 9:3, pages e025002.
Crossref
Justin Gagnon, Marie-Thérèse Lussier, Brenda MacGibbon, Stella S. Daskalopoulou & Gillian Bartlett. (2018) The Impact of Antidepressant Therapy on Glycemic Control in Canadian Primary Care Patients With Diabetes Mellitus. Frontiers in Nutrition 5.
Crossref
Mohamed Balaha, Samah Kandeel & Ahmed Kabel. (2018) Phloretin either alone or in combination with duloxetine alleviates the STZ-induced diabetic neuropathy in rats. Biomedicine & Pharmacotherapy 101, pages 821-832.
Crossref
Hitoshi Yasuda, Nigishi Hotta, Masato Kasuga, Atsunori Kashiwagi, Ryuzo Kawamori, Tadaaki Yamada, Yuko Baba, Levent Alev & Ko Nakajo. (2015) Efficacy and safety of 40 mg or 60 mg duloxetine in J apanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study . Journal of Diabetes Investigation 7:1, pages 100-108.
Crossref
Michael Happich, Edith Schneider, Frank G. Boess, Stefan Wilhelm, Alexander Schacht, Frank Birklein & Dan Ziegler. (2014) Effectiveness of Duloxetine Compared With Pregabalin and Gabapentin in Diabetic Peripheral Neuropathic Pain. The Clinical Journal of Pain 30:10, pages 875-885.
Crossref
G. Irving, R. J. Tanenberg, J. Raskin, R. C. Risser & S. Malcolm. (2014) Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain. International Journal of Clinical Practice 68:9, pages 1130-1140.
Crossref
Gabriella Deli, Edit Bosnyak, Gabriella Pusch, Samuel Komoly & Gergely Feher. (2013) Diabetic Neuropathies: Diagnosis and Management. Neuroendocrinology 98:4, pages 267-280.
Crossref
Wataru Nagashima, Hiroyuki Kimura, Mikiko Ito, Tatsuya Tokura, Munetaka Arao, Branko Aleksic, Keizo Yoshida, Kenichi Kurita & Norio Ozaki. (2012) Effectiveness of Duloxetine for the Treatment of Chronic Nonorganic Orofacial Pain. Clinical Neuropharmacology 35:6, pages 273-277.
Crossref
Vincenza Spallone, Marco Lacerenza, Andrea Rossi, Riccardo Sicuteri & Paolo Marchettini. (2012) Painful Diabetic Polyneuropathy. The Clinical Journal of Pain 28:8, pages 726-743.
Crossref
Paul R. Nandi. (2012) Pain in neurological conditions. Current Opinion in Supportive & Palliative Care 6:2, pages 194-200.
Crossref
R. Taliyan & P.L. Sharma. (2010) Diabetic Neuropathic Pain: An Update and Novel Pharmacological Strategies for Relief of Pain. Journal of Medical Sciences 10:4, pages 93-109.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.